Mouse Hybridoma Clone 4D12 Against Human HLA-E (4D12 Hybridoma, TID 00544)
Researchers at Fred Hutchinson Cancer Center have developed a new hybridoma cell line that expresses mouse anti-human HLA-E antibodies.
Reference:
- Geraghty et al., J. Immunol. 1998; 1604651-4960 “HLA-E Surface Expression Depends on Binding of TAP-Dependent Peptides Derived from Certain HLA Class I Signal Sequences”
Available Licenses
To license this product, please complete, sign and return the license agreement to bds@fredhutch.org. Further instructions are provided therein.
Please Note: Academic and non-profit users may license the material for free. Fees for for-profit users are listed in the license agreements. All recipients must pay a fee for material preparation and shipping expenses.
Download license agreement
Commerical Use | Non-commerical Use
Credit Line for Acknowledgement
When publishing on the use of this material, please provide credit to Dr. Daniel Geraghty according to accepted publications standards.
Questions About this Product?
